Use of an injectable, sustained-release formulation of moxidectin to prevent canine subcutaneous dirofilariosis

Vet Rec. 2004 Jan 3;154(1):26-7. doi: 10.1136/vr.154.1.26.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Animals
  • Delayed-Action Preparations
  • Dirofilariasis / prevention & control*
  • Dog Diseases / prevention & control*
  • Dogs
  • Female
  • Filaricides / administration & dosage*
  • Injections, Subcutaneous / veterinary
  • Macrolides / administration & dosage*
  • Male
  • Treatment Outcome

Substances

  • Delayed-Action Preparations
  • Filaricides
  • Macrolides
  • moxidectin